文献速递细菌感染、耐药与抗菌药物医院感染防控

重症患者肠道菌群变化与多重耐药菌定植、感染及死亡风险

Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients.
PubMed 文献 · Clin Microbiol Infect · 2022-01-20

前瞻性研究纳入2018年7月至12月一间12张床位的肝脏ICU收治的患者,对62例患者的138份直肠拭子行16S rRNA基因测序,评估肠道菌群组成与多样性与多重耐药菌定植、感染及住院死亡风险的关联。结果显示,菌群多样性较高及特定菌群丰度与较低风险相关,肠球菌科与感染和死亡风险升高相关;作者认为部分菌群标志物可能具有预后价值,需更大规模前瞻性研究验证。

要点

  • 62例中19例(30.65%)入院时已定植多重耐药菌,16例(25.81%)住院期间定植,27例(43.55%)未定植。
  • 菌群多样性较高及Bacillales Family XI incertae sedis、普雷沃菌科丰度较高与定植、感染和死亡风险较低相关(LEfSe评分>4)。
  • 肠球菌科与感染和死亡风险升高相关(LEfSe评分>4);Family XI incertae sedis与感染风险较低相关(OR 0.997,95%CI 0.996-0.999,p=0.001)。

核心结论

  • 肠道菌群多样性和某些细菌类群的丰度可能对重症监护病房患者具有预后价值。
  • 作者认为需要更大规模的前瞻性研究评估这些标志物在临床实践中的价值。

研究设计与样本

  • 前瞻性研究,纳入2018年7月至12月一间12张床位的肝脏ICU收治的患者。
  • 在ICU入院时及住院期间每周采集直肠拭子检测多重耐药菌肠道定植,对62例患者的138份直肠拭子行16S rRNA基因测序。
  • 评估肠道菌群组成与多样性与多重耐药菌定植、感染及住院死亡风险的潜在关联。

主要发现

  • 62例中19例(30.65%)入院时存在多重耐药菌定植,16例(25.81%)住院期间定植,27例(43.55%)未定植;45例(72.58%)发生感染,死亡18例(29.03%)。
  • 菌群多样性较高及Bacillales Family XI incertae sedis和普雷沃菌科丰度较高与多重耐药菌定植、感染和死亡风险较低相关(线性判别分析效应量评分>4)。
  • 肠球菌科与感染和死亡风险升高相关(线性判别分析效应量评分>4)。
  • LASSO回归和多因素分析显示Family XI incertae sedis与感染风险较低相关(OR 0.997,95%CI 0.996-0.999,p=0.001),微生物均匀度指数与死亡风险较低相关(OR 0.68,95%CI 0.49-0.95,p=0.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要更大规模的前瞻性研究评估这些标志物在临床实践中的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to investigate whethehr the diversity and composition of the intestinal microbiota determines the risk of multidrug-resistant organism (MDRO) acquisition, infection, and mortality in patients admitted to a liver intensive care unit (ICU). METHODS: This prospective study included patients admitted to a 12-bed ICU between July and December 2018. Rectal swabs to detect MDRO intestinal colonization were obtained at ICU admission and weekly thereafter during the ICU stay. The 16S rRNA gene sequencing was performed on 138 rectal swabs from 62 patients. We evaluated the potential association between gut microbiota composition and diversity and the risk of MDRO colonization, infection, and hospital mortality. RESULTS: Of the patients studied, 19 of 62 (30.65%) presented with MDRO colonization at admission, 16 (25.81%) were colonized during their stay, and 27 (43.55%) were not colonized; 45 of 62 patients (72.58%) developed an infection, and mortality was 29.03% (18 of 62). Higher bacterial diversity and abundance of Bacillales Family XI incertae sedis and Prevotella families were associated with a lower risk of colonization by MDRO, infection, and death (linear discriminant analysis effect size score >4), whereas the Enterococcaceae family was associated with an increased risk of infection and death (linear discriminant analysis effect size score >4). The LASSO regression and multivariate analysis identified Family XI incertae sedis to be associated with a lower risk of infection (OR: 0.997; 95% CI, 0.996-0.999; p = 0.001) and microbial evenness index to be associated with lower mortality risk (OR: 0.68; 95% CI, 0.49-0.95; p = 0.02). DISCUSSION: Microbial diversity and abundance of certain bacterial taxa could have prognostic value in patients admitted to a critical care unit. Larger perspective studies should address the value of these markers in clinical practice.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Garcia ER, Vergara A, Aziz F, et al. Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients. Clin Microbiol Infect. 2022. PMID: 35066206. doi:10.1016/j.cmi.2022.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。